To further delineate the role of CD4+/CD8+ cells in tumor rejection in Atg5flox/flox mice, the PC-61.5.3 antibody was used to deplete CD25+ cells in tumor-bearing Atg5+/+ mice (Figure S5C). This evidence concerns the gene CD8A and neoplasm.